Detalhe da pesquisa
1.
MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor.
Blood
; 121(20): 4115-25, 2013 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-23532732
2.
PIKFYVE inhibitors trigger interleukin-24-dependent cell death of autophagy-dependent melanoma.
Mol Oncol
; 18(4): 988-1011, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38414326
3.
PIP5K1C phosphoinositide kinase deficiency distinguishes PIKFYVE-dependent cancer cells from non-malignant cells.
Autophagy
; 19(9): 2464-2484, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36803256
4.
Selective elimination of pluripotent stem cells by PIKfyve specific inhibitors.
Stem Cell Reports
; 17(2): 397-412, 2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35063131
5.
PIKfyve-specific inhibitors restrict replication of multiple coronaviruses in vitro but not in a murine model of COVID-19.
Commun Biol
; 5(1): 808, 2022 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35962188
6.
Histone deacetylase inhibitors: emerging mechanisms of resistance.
Mol Pharm
; 8(6): 2021-31, 2011 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-21899343
7.
R-Loop-Mediated ssDNA Breaks Accumulate Following Short-Term Exposure to the HDAC Inhibitor Romidepsin.
Mol Cancer Res
; 19(8): 1361-1374, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34050002
8.
Identification of compounds that correlate with ABCG2 transporter function in the National Cancer Institute Anticancer Drug Screen.
Mol Pharmacol
; 76(5): 946-56, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19633067
9.
Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial.
JAMA Oncol
; 4(10): 1405-1409, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29955793
10.
Circulating microRNAs in cancer: Hope or hype?
Cancer Lett
; 381(1): 113-21, 2016 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27471105
11.
Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras.
Oncotarget
; 7(43): 69804-69815, 2016 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27634878
12.
SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer.
Clin Cancer Res
; 22(10): 2396-404, 2016 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26671993
13.
Histone deacetylase inhibitor-mediated cell death is distinct from its global effect on chromatin.
Mol Oncol
; 8(8): 1379-92, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24954856
14.
Loss of the proteins Bak and Bax prevents apoptosis mediated by histone deacetylase inhibitors.
Cell Cycle
; 12(17): 2829-38, 2013 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23966164